TELA Bio, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $4.2M |
| Cost of Revenue | $1.7M |
| Gross Profit | $2.5M |
| Gross Margin | 59.6% |
| Operating Expenses | |
| Research & Development | $5.8M |
| SG&A Expense | $5.0M |
| Operating Income | $-16.9M |
| Operating Margin | -398.7% |
| Interest Expense | $4.6M |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-21.3M |
| Net Margin | -502.6% |
| EPS (Basic) | — |
| EPS (Diluted) | — |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |